EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent advances in biosensing platforms utilizing exosomal biomarker profiling for cancer diagnosis

Sojin Song, Sujin Hyung, Jeeyun Lee, Hong Nam Kim, Nakwon Choi

Biosensors and Bioelectronics · 2026-10 · 309 · 118809

DOI: 10.1016/j.bios.2026.118809 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biosensors and Bioelectronics, 2026-10. Verfasst von Sojin Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea. Hauptthemen laut MEDLINE: Exosomes, Biosensing Techniques, Biomarkers, Tumor, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Institute of Science and Technology, Korea Ministry of Food and Drug Safety, Korea Ministry of Science and ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-derived exosomes carry multidimensional molecular cargo, including surface proteins, microRNAs, and lipids that encode tumor identity and disease dynamics. These features support their application as biomarkers for liquid biopsy-based cancer diagnostics. Circulating tumor DNA undergoes rapid nuclease-mediated degradation, whereas exosomes retain stable molecular information that reflects the proteomic, transcriptomic, and metabolic states of parent tumor cells. However, clinical translation of exosome-based sensing remains limited by variability in isolation, biological heterogeneity, and the analytical difficulty of detecting low-abundance biomarkers in clinical samples. In this review, we examine cancer-specific exosomal signatures across breast, lung, colorectal, and gastric cancers and evaluate biosensing platforms for exosomal biomarker profiling. We integrate engineering principles, clinical performance metrics, and AI-assisted analysis across complementary biosensing modalities to establish a cross-platform analytical framework. We compare optical platforms based on surface plasmon resonance, localized surface plasmon resonance, and surface-enhanced Raman scattering with photoluminescence- and electrochemical-based platforms in terms of sensitivity, clinical compatibility, and translational potential. Furthermore, we examine artificial intelligence (AI)-assisted biosensing frameworks, including classical machine learning classifiers, deep convolutional networks, ensemble models, explainable AI methods, and large language model interfaces. We evaluate how each framework addresses high-dimensional spectral complexity, nonlinear relationships among signals, and inter-patient variability in exosomal data. Finally, we identify remaining challenges, such as the lack of standardized isolation protocols and the absence of large-scale clinical validation. We further highlight minimal residual disease monitoring and early-stage cancer detection as important and underexplored directions for AI-integrated exosomal biosensing in precision oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesBiosensing TechniquesBiomarkers, TumorNeoplasmsHumansArtificial IntelligenceLiquid Biopsy

Stichwörter der Autor:innen

Artificial intelligenceBiosensorCancerDiagnosisExosomeLiquid biopsy

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
  • Samsung Precision Genome Medicine Institute, Samsung Medical Center, Seoul, 06351, Republic of Korea; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Me…
  • Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea; Division of Bio-Medical Science and Technology, KIST School, University of Science and Technology (UST), Seoul,…
  • Department of Biomedical Sciences, College of Medicine, Korea University, Seoul, 02841, Republic of Korea; Department of Convergence Medicine, College of Medicine, Korea University, Seoul, 02841, Republic of Korea; Inst…

Förderung

  • Korea Institute of Science and Technology
  • Korea Ministry of Food and Drug Safety
  • Korea Ministry of Science and ICT
  • National Research Foundation of Korea
  • Korea Ministry of Education

Zitieren

APA

Song, S., Hyung, S., Lee, J., Kim, H. N., & Choi, N. (2026). Recent advances in biosensing platforms utilizing exosomal biomarker profiling for cancer diagnosis. Biosensors and Bioelectronics, 309, 118809. https://doi.org/10.1016/j.bios.2026.118809

Vancouver

Song S, Hyung S, Lee J, Kim HN, Choi N. Recent advances in biosensing platforms utilizing exosomal biomarker profiling for cancer diagnosis. Biosensors and Bioelectronics. 2026;309:118809. doi:10.1016/j.bios.2026.118809

BibTeX
@article{Song2026,
  author = {Song, Sojin and Hyung, Sujin and Lee, Jeeyun and Kim, Hong Nam and Choi, Nakwon},
  title = {Recent advances in biosensing platforms utilizing exosomal biomarker profiling for cancer diagnosis},
  journal = {Biosensors and Bioelectronics},
  year = {2026},
  volume = {309},
  pages = {118809},
  doi = {10.1016/j.bios.2026.118809}
}
Kostenlos starten →